An Open-Label, Single Centre Study to Assess the Pharmacokinetics and Pharmacodynamics of Warfarin When Co-Administered With Fostamatinib in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2016
At a glance
- Drugs Fostamatinib (Primary) ; Warfarin
- Indications B cell lymphoma; Chronic lymphocytic leukaemia; Rheumatoid arthritis; Solid tumours; T cell lymphoma; Thromboembolism; Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 09 Jan 2016 Results published in the Drugs in R and D
- 15 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.